Sec Form 13G Filing - Clearline Capital LP filing for TherapeuticsMD, Inc. (TXMD) - 2025-02-12

Insider filing report for Changes in Beneficial Ownership

  • Schedule 13G & 13D forms are used to report a party's ownership of stock which exceeds 5% of a company's total stock issue.
  • Schedule 13G is a shorter version of Schedule 13D with fewer reporting requirements.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Checkbox checked   Rule 13d-1(b)
Checkbox not checked   Rule 13d-1(c)
Checkbox not checked   Rule 13d-1(d)






SCHEDULE 13G




SCHEDULE 13G




SCHEDULE 13G




SCHEDULE 13G


 
Clearline Capital LP
 
Signature:Marc Majzner
Name/Title:Limited Partner
Date:02/12/2025
 
Clearline Capital, LLC
 
Signature:Marc Majzner
Name/Title:Managing Member
Date:02/12/2025
 
Marc Majzner
 
Signature:Marc Majzner
Name/Title:Authorized Signatory
Date:02/12/2025
Exhibit Information

Exhibit 1: Joint Filing Agreement

primary_doc.xml